Objective: The aim of this study was to evaluate the in¯uence of menopausal status, serum estradiol and body mass index (BMI) on serum leptin concentration in a large sample of pre-and postmenopausal women. Design: 434 healthy women (mean age 6 S.D., 52.2 6 10.3 years) were recruited at the University of Marburg on the occasion of a routine gynecological visit. Two hundred and eighteen (50.2%) women were premenopausal (mean age, 36.5 6 10.4 years) and not on oral contraceptives or hormone replacement therapy (HRT) and 216 (49.8%) women were postmenopausal (mean age 61.8 6 8.9 years) not on HRT. To evaluate the in¯uence of menopausal status, estradiol level and BMI on serum leptin concentrations, women were allocated to one of the four groups: (a) premenopausal women BMI <25 kg/m 2 (n 137), (b) premenopausal women BMI >25 kg/m 2 (n 81), (c) postmenopausal women BMI <25 kg/m 2 (n 94) and (d) postmenopausal women BMI >25 kg/m 2 (n 122). Results: Irrespective of the menopausal status, women with a BMI >25 kg/m 2 had signi®cantly higher leptin concentrations in all age groups compared with women with a BMI <25 kg/m 2 (P < 0.001). The multiple linear regression analyses showed that BMI was the only statistically signi®cant independent predictor for leptin. In comparison to postmenopausal women, premenopausal women showed a signi®cantly lower mean age, weight, BMI and FSH concentration (P < 0.001), a higher mean height and serum estradiol (P < 0.01 and P < 0.001 respectively) but signi®cantly lower serum leptin concentration (P < 0.01). The multiple linear regression model showed no signi®cant in¯uence of menopausal status or serum estradiol on serum leptin concentration, even after controlling for BMI. Conclusions: Serum leptin concentrations are signi®cantly higher in pre-and postmenopausal obese women, compared with normal weight controls. Serum leptin concentrations are not in¯uenced by menopausal status or serum estradiol level.
Introduction
It is a common clinical observation that a large number of women gain body weight after menopause. Several clinical studies have demonstrated this effect (1±3). Central obesity increases after menopause, indicating that the loss of estrogen may not only increase body fat and weight, but also change body fat distribution (4) . It has been reported that long-term hormone replacement therapy (HRT) prevents the increase in body weight and skin-fold thickness observed after the menopause (5) . However, the exact mechanism of the menopausal effect on body weight and fat distribution after the loss of estrogen has not been fully determined in vivo. It has been suggested that there is a link between estradiol and leptin metabolism, production and/or action in postmenopausal women.
Leptin is the product of the ob gene and is expressed in adipose tissue (6±9). It appears to be a component of a regulatory loop linking fat mass to food intake and energy expenditure (10±12). Serum leptin concentrations are closely related to body fat content (13) , have a circadian rhythm (14) , are regulated by fasting plasma insulin concentrations (15±17) and differ between males and females (18, 19) . Leptin concentrations have been reported to be 2±4 times higher in females than in males (18±21). Most data suggest that there are gender differences in leptin concentrations that are unexplained by differences in obesity. Additionally, females seem to be more sensitive to exercise-induced changes in leptin concentrations than males, even in the absence of any change in fat mass (20, 22) . The mechanism for the gender dichotomy in the leptin±fat mass relationship, and for the greater sensitivity of leptin to change in energy balance in women is not apparent. Since there is a residual variability in leptin levels, environmental factors, genetics, gender and other factors besides obesity may also in¯uence serum leptin concentrations. It has been suggested that there is a link between sex steroids and leptin production/action in humans (23) . Only a few studies have evaluated the relationship between serum estradiol and leptin concentrations. These studies investigated different proportions of males and females, some only postmenopausal, some only premenopausal women and included mainly small sample sizes leading to con¯icting results (19±20, 23). We therefore studied a large sample of normal weight and obese, pre-and postmenopausal women not on oral contraceptives or HRT to determine the in¯u-ence of menopausal status, serum estradiol and body mass index (BMI) on serum leptin concentrations. We hypothesized that if estradiol plays a regulatory role in leptin production, leptin levels would be expected to vary as a function of the presence or absence of estrogen.
Methods

Subjects
Four hundred and thirty-four women (age range 30±86 years; mean 6 S.D., 52.2 6 10.3 years) participated in the study. They were recruited from women attending the department of obstetrics and gynecology of the University of Marburg for routine gynecological checkup. Before entry to the study, all women had answered a detailed questionnaire on important risk factors and gave written informed consent. Exclusion criteria contained known cardiovascular disease, diabetes and medication such as lipid-lowering drugs, corticosteroids, thyroid hormone oral contraceptives or HRT which could alter metabolism. Anthropometric measurements (weight and height) were made with the participant wearing an examining gown after having removed shoes. BMI was calculated as weight (in kilograms) divided by height (in meters) squared. Women with a BMI >25 kg/m 2 were classi®ed as obese and women with a BMI of <25 kg/m 2 were classi®ed as not obese. We considered women to be postmenopausal if they had a hysterectomy and bilateral oophorectomy and/or had no menstrual periods in the year preceding their examination and/or had a serum follicle-stimulating hormone (FSH) concentration of 30 >IU/l and a serum estradiol level of <10 pg/ml. Women taking HRT were excluded from the study. All blood samples were collected in the morning to gain comparable results. Women were considered premenopausal if they had regular periods in the year preceding their examination and/or had a serum FSH of 30 <IU/l and a serum estradiol level of >10 pg/ml. We restricted analyses to non-pregnant premenopausal women who did not take oral contraceptives.
Ethical approval
The study received the approval of the ethical committee of the University of Marburg and was carried out according to the requirements of the declaration of Helsinki.
Study design
In the initial analysis, we compared non-pregnant premenopausal women (n 218) with postmenopausal women who had not used HRT (n 216). In order to reduce any bias introduced by confounding variables such as age, weight, height and BMI, we separately analyzed the groups according to their BMI. Women with a BMI >25 kg/m 2 were classi®ed as obese while women with a BMI of <25 kg/m 2 were classi®ed as not obese. Eligible subjects were assigned to the following groups: 
Assays
Serum leptin was measured by a commercial RIA (Linco Research, Inc., St Louis, MO, USA). The intraassay coef®cient of variation was 3.4±8.3%, and the interassay coef®cient of variation was 3.6±6.2%.
Serum estradiol was measured by a solid phase RIA (Diagnostic Products Corporation, Los Angeles, CA, USA). The lower limit of detectability was 8 pg/ml, and the intraassay and interassay coef®cients of variation were 5.3% and 6.4% respectively. Serum FSH was measured by a highly sensitive IRMA assay (Biochem Immunosystems Co., Freiburg, Germany). Intraassay and interassay coef®cients of variation were 6.1% and 6.5% respectively. The detection limit was 0.5 IU/l.
Statistical analysis
Data analyses were performed using SPSS 9.0 for Windows. Two-tailed tests were used throughout and the level of statistical signi®cance set at 0.05. The skewness and kurtosis of the distribution of all variables were controlled and found to be normally distributed. Differences in patients characteristics and serum leptin, FSH and estradiol concentrations between pre-and postmenopausal women were calculated using t-test. In order to evaluate differences between the de®ned groups we used ANOVA with the Bonferroni-adjusted probabilities for post hoc analysis. Because of the large number of statistical comparisons, the likelihood of Type I errors is increased for each analysis. The Bonferroni method adjusts probabilities based on the number of tests carried out for each analysis. The independent effects of predictor variables were analyzed by stepwise multiple regression analysis. Table 1 shows the baseline characteristics of both groups. Premenopausal women showed a signi®cantly lower mean age, weight, BMI and FSH concentration (P < 0.001), a higher mean height and serum estradiol (P < 0.01 and P < 0.001) but signi®cantly lower serum leptin concentration (P < 0.01) in comparison to postmenopausal women. Our results showed that women with a BMI >25 kg/m 2 had signi®cantly higher serum leptin concentrations irrespective of the menopausal status (Fig. 1) .
Results
In order to reduce the bias due to the signi®cant group differences in BMI, women were grouped according to their menopausal status and BMI (Table 2) . Premenopausal women with a BMI <25 kg/m 2 showed a signi®cantly lower mean age, weight, BMI and serum leptin concentration (P<0.001) as well as a higher mean height (P < 0.05) in comparison to premenopausal women with a BMI >25 kg/m 2 . There were no signi®cant differences in serum estradiol and serum FSH concentration between the groups.
Postmenopausal women with a BMI <25 kg/m 2 showed a signi®cantly lower weight, BMI and serum leptin concentration (P < 0.001) as well as a higher mean serum FSH concentration (P < 0.001) in comparison to postmenopausal women with a BMI >25 kg/m 2 . There were no signi®cant differences in mean age, mean height and mean serum estradiol concentration between the groups (Table 2) .
We performed ANOVA to compare pre-and postmenopausal women with a BMI below and above 25 kg/ m 2 . The model was highly signi®cant (F 27.37 with P < 0.001). The post hoc analysis (signi®cance level P 0.05) revealed signi®cant mean differences for serum leptin concentrations between the de®ned groups as follows: between group a vs b and d, group b vs a and c, group c vs b and d and between group d vs a and c.
Our results indicate that the signi®cant differences in serum leptin concentration in the premenopausal and postmenopausal women were only in¯uenced by BMI. There was no in¯uence of menopausal status on serum leptin concentration (Fig. 2) .
We additionally performed a multiple regression analysis with leptin as the continuous variable to evaluate the independent in¯uence of BMI on serum leptin concentration. The following variables were entered into stepwise multiple linear regression models: age, weight, height, BMI, menopausal status (pre-vs postmenopausal), estradiol and FSH. Hereby, only BMI remained as a statistically signi®cant independent predictor for leptin (R 2 0.17; Model: F 125.07 with P<0.0001). The multiple linear regression model showed no signi®cant effect for menopausal status or serum estradiol on serum leptin concentration.
Finally, we plotted the serum leptin concentration of premenopausal women (serum estradiol concentration >10 pg/ml) and postmenopausal women (serum estradiol concentration <10 pg/ml) in relation to the BMI (Fig. 3 ).
Discussion
Our results on a large sample of healthy pre-and postmenopausal women demonstrate that obese women have signi®cantly higher leptin concentrations than women with normal weight. Our study indicates that neither menopause nor serum estradiol alters serum leptin concentration. This effect persisted even after controlling for BMI in a multiple linear regression analyses.
The role of serum leptin in humans is still controversial. Serum leptin concentration is increased in obese subjects and is closely related to fat mass (FM) and BMI (13, 19) . It is regulated by serum insulin concentration (25) and declines with weight loss (13) . Several reports have shown a higher leptin concentration in women than in men (18 distribution of the amount of body fat depots. Women tend to have a higher overall obesity which is more pronounced in subcutaneous fat than in visceral fat, in contrast to men who have a lower overall but greater visceral adiposity. Lo Ènnqvist et al. reported that subcutaneous fat produced more leptin mRNA than visceral fat (8) . This may also help to explain a part of the sexual dimorphism in leptin levels. Ostlund et al. and Haffner et al. reported higher leptin concentrations in women than in men even after adjustment for obesity assessed by subcutaneous skinfolds (21, 23) . In contrast, two reports by Considine et al. and Maffei et al. showed no difference between women and men after adjustment for percentage of body fat assessed by bioimpedance (13, 26) . It has also been hypothesized that gender differences of serum leptin concentrations between men and women can partly be explained by differences in serum estradiol levels. A study by Barash et al. (27) suggested that serum leptin concentrations seem to modulate gonadal activity. Ovarian and testicular weight increased in this study after treatment with leptin and histological examination demonstrated a larger amount of follicular development in ovarian tissue and elevated cellular activity in seminiferous tubules in the testis. More recently, Ahima et al. hypothesized that leptin acts as a signal triggering puberty (28) . A study by Shimizu et al. also suggested that estradiol raises leptin levels in humans. They found that serum leptin was about 33% higher during luteal phase of menstrual cycle while estradiol concentrations were two-fold higher in comparison to follicular phase (29) . A report by Hardie et al. (30) with a similar design suggested that leptin levels are more closely associated with serum progesterone levels. These authors also reported that during gestation, serum leptin concentration correlates closely with estradiol and not with progesterone.
Today, the in¯uence of serum estradiol concentration on serum leptin is still poorly understood. Hickey et al. (20) recently analyzed data on postmenopausal women participating in a Cardiovascular Risk Factor Identi®cation Program. Women were matched for age, aerobic capacity and obesity. Despite a four-fold variation in serum estradiol, serum leptin concentration was not different in HRT users and non-users. A previous study by Haffner et al. (23) analyzing a small but well-matched number of Mexican American women selected from the San Antonio Heart Study also showed no relation of serum leptin concentration to menopausal status or postmenopausal hormone use. These and other ®ndings including our own results argue against the hypothesis that differences of serum leptin concentrations between men and women can be explained by differences in serum estradiol levels (31, 32) . In contrast, a more recent report by Paolisso et al. (24) on a much younger population showed a high correlation of serum leptin with estradiol or testosterone concentrations in men and with estradiol concentration in women after adjustment for age, amount of body fat and waist to hip ratio (WHR). The authors hypothesized that the relationship between sex hormones and serum leptin concentration could also be mediated through the effect of sex hormones on body fat content and concentration, since in vitro studies demonstrated a direct relationship between serum estradiol levels and BMI (24, 33) .
In conclusion, our study on a large sample of healthy pre-and postmenopausal women demonstrates that neither menopause nor serum estradiol alters plasma leptin concentration even after controlling for BMI in a multiple linear regression analyses. Hereby, only BMI remained as a statistically signi®cant independent predictor for leptin. However, the role of leptin in humans is still poorly understood. The existing reports show inconclusive results on the interaction of serum leptin concentration and estradiol levels. If, how and why serum estradiol levels might in¯uence serum leptin concentration needs to be investigated in further longitudinal and interventional studies.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000) 143
www.eje.org Figure 3 Correlation and regression line between serum leptin concentration and BMI in premenopausal (n 218, estradiol >10 pg/ml) and postmenopausal women (n 216, estradiol < 10 pg/ml).
